With US life-sciences group Agilent Technologies Inc. agreeing to pay €68m for Multiplicom N.V, investors in the Belgian molecular diagnostic test kit-maker can look forward to a sizeable return on investment.
Multiplicom was spun out of the University of Antwerp and the research institute VIB in 2011. In addition to these...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?